SCHEMBL32665449

SCHEMBL32665449

NCC1CCN(c2cccc(OS(=O)(=O)F)c2)CC1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BPTF Q12830 1/20 0.51
MAPT P10636 1/20 0.38
TPSAB1 Q15661 3/20 0.38
NOTUM Q6P988 1/20 0.38
FFAR4 Q5NUL3 2/20 0.37
CHRM4 P08173 3/20 0.37
CHRM2 P08172 1/20 0.36
CHRM1 P11229 1/20 0.36
ADRA1D P25100 1/20 0.36
ADRA1A P35348 1/20 0.36
ADRA1B P35368 1/20 0.36
DKK1 O94907 1/20 0.36
HTR1A P08908 1/20 0.35
HTR2A P28223 1/20 0.35
HTR2C P28335 1/20 0.35
HTR7 P34969 1/20 0.35
DRD3 P35462 1/20 0.35
HTR6 P50406 1/20 0.35
HRH1 P35367 1/20 0.35
CCR3 P51677 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL32665624 0.85 VCP (0.42) BPTFMAPTNOTUMHTR6GUSB
SCHEMBL32665273 0.83 NOTUM (0.38) BPTFMAPTNOTUMGUSBALDH1A1
SCHEMBL32665195 0.82 HRH1 (0.37) BPTFMAPTTPSAB1NOTUMFFAR4
SCHEMBL32665631 0.81 BPTF (0.53) BPTFTPSAB1CHRM4HTR1AHTR2A
SCHEMBL32665255 0.80 NOTUM (0.43) BPTFNOTUMHTR1AHTR6ALDH1A1
SCHEMBL32665250 0.80 NOTUM (0.43) BPTFNOTUMHTR1AHTR6ALDH1A1
SCHEMBL32665021 0.80 HTR1A (0.38) NOTUMCHRM4CHRM2CHRM1HTR1A
SCHEMBL8124584 0.79 ADRB1 (0.56) BPTFMAPTFFAR4CHRM4ADRA1D
SCHEMBL32665285 0.77 ALDH1A1 (0.36) MAPTNOTUMHTR7GUSBALDH1A1
SCHEMBL32665450 0.73 NOTUM (0.40) BPTFNOTUMALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260021192-A1 PROTEINS HAVING A COVALENT WARHEAD TOPAZ THERAPEUTICS INC (US) 2026-01-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260021192-A1 PROTEINS HAVING A COVALENT WARHEAD RIOX2, ORC3, DCLRE1A BPTF 2276/4885MAPT 4709/4885TPSAB1 2412/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.